cefiderocol
A fourth-generation siderophore cephalosporin antibiotic having {1-[2-(2-chloro-3,4-dihydroxybenzamido)ethyl]pyrrolidinium-1-yl}methyl and [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino side groups located at positions 3 and 7 respectively, developed to combat a variety of bacterial pathogens, including β-lactam- and carbapenem-resistant organisms.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
cephalosporinARO:0000032
- cephalosporin
CHEBI:23066 -
CHEBI:33575 - cephalosporin
ARO:0000032
Chemical structure
| Molecular formula | C30H34ClN7O10S2 |
|---|---|
| Charge | 0 |
| Average mass | 752.228 Da |
| Monoisotopic mass | 751.14971 Da |
| Source | ChEBI |
| InChIKey | DBPPRLRVDVJOCL-FQRUVTKNSA-N |
[H][C@]12SCC(C[N+]3(CCNC(=O)c4ccc(O)c(O)c4Cl)CCCC3)=C(C(=O)[O-])N1C(=O)[C@H]2NC(=O)/C(=N\OC(C)(C)C(=O)O)c1csc(N)n1
InChI=1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1
Also called
- cefiderocolum
- céfidérocol
- (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-3-({1-[2-(2-chloro-3,4-dihydroxybenzamido)ethyl]pyrrolidinium-1-yl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- GSK 2696266
- GSK-2696266
- GSK2696266
- RSC 649266
- S 649266
- S-649266
- S649266
Cross-references
- cefiderocol
ARO:3004474 - cas:1225208-94-5
- chemspider:52084902
- reaxys:21605074
- chembl:CHEMBL3989974
- pubchem.compound:77843966
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3004474 |
cefiderocol | antibioticmech:aro-eabc5c702e |
2026-08-30 |
| CHEBI | CHEBI:140376 |
cefiderocol | antibioticmech:chebi-1e15875db2 |
2026-08-30 |
Activity spectrum
| Organism | Activity | MIC | Disk diffusion | Assay | Strain | Sample/genome | Evidence |
|---|---|---|---|---|---|---|---|
| Acinetobacter baumannii NCBITaxon:470 | — | 16.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; CDC/FDA AR Isolate Bank reports an R interpretation without a versioned breakpoint footnote on this isolate page. | 0033 |
BioSample SAMN04014874 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | 16.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2024 M100 S34 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0078 |
BioSample SAMN04014919 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | >32.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2020 M100 S30 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0083 |
BioSample SAMN04014924 |
EvidencePage data (JSON.gz) |
| Acinetobacter baumannii NCBITaxon:470 | — | >32.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2024 M100 S34 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0088 |
BioSample SAMN04014929 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | >32.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0118 |
BioSample SAMN04014959 |
EvidencePage data (JSON.gz) |
| Klebsiella pneumoniae NCBITaxon:573 | — | 16.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0143 |
BioSample SAMN04014984 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | >32.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0150 |
BioSample SAMN04014991 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | >64.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0151 |
BioSample SAMN04014992 |
EvidencePage data (JSON.gz) |
| Escherichia coli NCBITaxon:562 | — | >32.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0162 |
BioSample SAMN04015003 |
EvidencePage data (JSON.gz) |
| Pseudomonas aeruginosa NCBITaxon:287 | — | 16.0 mg/L | — | Broth microdilution cefiderocol MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35 per the CDC/FDA AR Isolate Bank Panel 1227 footnote. | 0246 |
BioSample SAMN04901636 |
EvidencePage data (JSON.gz) |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
CURATED_RESISTANT_TAXA
Added 10 stable-URL CDC/FDA AR Isolate Bank Panel 1227 cefiderocol-resistant MIC observations.
-
STRUCTURED_ACTIVITY_BIOSAMPLE_ACCESSIONS
Structured BioSample accessions on 10 activity_spectrum observation(s) where evidence notes already named exactly one accession.